Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Distribute Altona RT-PCR Ebola Test

NEW YORK (GenomeWeb) — Qiagen announced today it will offer global distribution of the Altona Diagnostics RealStar Ebolavirus RT-PCR Kit 1.0.

Manufactured and developed by Hamburg, Germany-based Altona, the diagnostic kit can detect all known strains of Ebola viruses, including the Zaire strain driving the current epidemic in West Africa.

"We are making Ebola diagnostic workflows accessible to public health authorities, scientists, and healthcare providers through our commercial networks around the world, including in Africa," Qiagen CEO Peer Schatz said in a statement.

The US Food and Drug Administration issued an Emergency Use Authorization for the kit on Nov. 10.

The distribution agreement expands an existing collaboration between the two firms. Qiagen is also distributing the RealStar Filovirus RT-PCR kit, which tests for Ebola and Marburg viruses.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.